Finance

Lists
Why is 182400 down 100,00%?
Dive Deeper
182400:KOSDAQ
NKGen Biotech Korea Co ltd
-100,00%
(-3 670,00) 1D
20 նոյ, 06:54:25 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 182400...
Mkt. cap
172,75 մլրդ
Volume
0,00
52-wk high
9 904 ₩
52-wk low
8 621 ₩
EPS
-77 ₩
Shares outstanding
72,34 մլն
No. of employees
65
Mkt. cap
172,75 մլրդ
Volume
0,00
52-wk high
9 904 ₩
52-wk low
8 621 ₩
EPS
-77 ₩
Shares outstanding
72,34 մլն
No. of employees
65
News stories
From web sources and news partners
About NKGen Biotech Korea Co ltd
CEO-
Employees65
Founded2002
Headquarters-
SectorHealth Care
Industry-
Websitenkmax.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
2,21 մլրդ
1,57 մլրդ
2,14 մլրդ
2,34 մլրդ
Cost of goods sold
578,36 մլն
241,90 մլն
410,63 մլն
376,08 մլն
Cost of revenue
578,36 մլն
241,90 մլն
410,63 մլն
376,08 մլն
Research and development expenses
454,60 մլն
472,72 մլն
358,00 մլն
575,57 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,29 մլրդ
1,33 մլրդ
1,19 մլրդ
1,10 մլրդ
Operating expense
4,57 մլրդ
2,22 մլրդ
1,86 մլրդ
1,91 մլրդ
Total operating expenses
5,15 մլրդ
2,46 մլրդ
2,27 մլրդ
2,29 մլրդ
Operating income
-2,93 մլրդ
-890,12 մլն
-129,89 մլն
48,66 մլն
Other non operating income
-619,47 մլն
-145,46 հզր
3,31 մլն
13,11 մլն
EBT including unusual items
-782,85 մլն
-592,63 մլն
-176,78 մլն
-316,33 մլն
EBT excluding unusual items
-3,68 մլրդ
-626,82 մլն
-142,96 մլն
-240,14 մլն
Income tax expense
-
-27,79 մլն
13,90 մլն
-
Effective tax rate
-
4,69%
-7,86%
-
Other operating expenses
41,92 մլն
58,49 մլն
40,23 մլն
47,64 մլն
Net income
-782,85 մլն
-564,84 մլն
-190,68 մլն
-316,33 մլն
Net profit margin
-35,41%
-35,87%
-8,92%
-13,54%
Earnings per share
-
-
-
-
Interest and investment income
-
27,58 մլն
16,91 մլն
16,62 մլն
Interest expense
-84,93 մլն
-120,33 մլն
-119,12 մլն
-117,64 մլն
Net interest expenses
-84,93 մլն
-92,75 մլն
-102,21 մլն
-101,02 մլն
Depreciation and amortization charges
79,26 մլն
200,33 մլն
251,59 մլն
252,98 մլն
EBITDA
-2,84 մլրդ
-675,04 մլն
136,47 մլն
316,43 մլն
Gain or loss from assets sale
106,27 մլն
-
-369,97 մլն
213,77 հզր
Upcoming events
AI content may include mistakes. Learn more
Google Apps